Status:

COMPLETED

Ovarian Function With ENG Implant and UPA Use

Lead Sponsor:

University of Utah

Collaborating Sponsors:

Merck Sharp & Dohme LLC

Conditions:

Contraception

Eligibility:

FEMALE

18-35 years

Phase:

EARLY_PHASE1

Brief Summary

Same day initiation of the etonogestrel (ENG) implant and oral ulipristal acetate (UPA) would overcome contraceptive access barriers to people capable of pregnancy with recent unprotected intercourse ...

Detailed Description

Primary Objectives: 1. To determine point estimates for the incidence of ovulation within five days of oral ulipristal acetate (UPA) administration with same day etonogestrel (ENG) implant insertion ...

Eligibility Criteria

Inclusion

  • Healthy females, age 18-35
  • Fluent in English
  • BMI \< 30 kg/m2
  • No known contraindication to either the ENG contraceptive implant or Ulipristal Acetate (UPA) using the CDC Medical Eligibility Criteria for Contraceptive Use 2016
  • Not current pregnant and not at risk of pregnancy (defined as not having penile-vaginal intercourse or using a non-hormonal method of contraception such as a barrier method, condoms, diaphragm, or cervical cap, a copper IUD, or permanent contraception)
  • Know the date of last menstrual period
  • Have a regular menstrual cycle (24-35 days)
  • Be willing to comply with all study requirements
  • Be willing to avoid pregnancy for the duration of the study

Exclusion

  • Currently pregnancy or breastfeeding
  • Use of hormonal contraception or exogenous hormones (estrogen, progestogen, or HCG) in the last month (or past 6 months for depo medroxyprogesterone acetate) or planned use of such during the study
  • Vaginal bleeding of unknown etiology
  • Allergy to UPA or ENG
  • Regular or planned use of glucocorticoids during the study
  • Current or planned use of any medication that potentially interacts with UPA or ENG

Key Trial Info

Start Date :

September 4 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 12 2024

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04291001

Start Date

September 4 2020

End Date

January 12 2024

Last Update

July 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Utah

Salt Lake City, Utah, United States, 84132